X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Dr. Reddys Fact Sheet, Dr. Reddys Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Dr. Reddys Fact Sheet    (REDY)

Here is the latest financial fact sheet of Dr. Reddys. For more details, see the Dr. Reddys quarterly results and Dr. Reddys share price and chart. For a sector overview, read our pharmaceuticals sector report.

DR. REDDYS LAB Price History

Price Rs 2,655.5
Mkt Cap Rs m 440,043
Vol '000 12.9
P/E X 23.0
P/CF X 14.5
EPS (TTM) Rs 115.5
% ch % -0.4
No. of shares m 165.71
% ch week % 0.1
% ch 1-mth % 2.5
% ch 12-mth % 28.6
52 week H/L Rs 2,965.2/2,017.2
(As on Jul 18, 2019 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

DR. REDDYS LAB Financials

No. of Mths
Year Ending
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
5-Yr Chart
Click to enlarge
DR. REDDYS LAB EQUITY SHARE DATA
High Rs3,6624,3833,3972,7882,875 
Low Rs2,2502,7502,5601,9021,888 
Sales per share (Unadj.) Rs881.8912.5856.5860.8930.2 
Earnings per share (Unadj.) Rs137.1124.978.057.1117.4 
Diluted earnings per shareRs141.0128.678.057.1117.7 
Cash flow per share (Unadj.) Rs181.7179.9139.9122.0185.8 
Dividends per share (Unadj.) Rs20.0020.0020.0020.0020.00 
Adj. dividends per shareRs20.5620.5920.0020.0220.04 
Dividend yield (eoy) %0.70.60.70.90.8 
Book value per share (Unadj.) Rs635.8736.8739.8757.7844.4 
Adj. book value per shareRs653.8758.5740.0758.7846.3 
Shares outstanding (eoy) m170.38170.61165.74165.91166.07 
Bonus/Rights/Conversions  ESOPESOPBBESOPESOP 
Price / Sales ratio x3.43.93.52.72.6 
Avg P/E ratio x21.628.638.241.120.3 
P/CF ratio (eoy) x16.319.821.319.212.8 
Price / Book Value ratio x4.64.84.03.12.8 
Dividend payout %14.616.025.735.017.0 
Avg Mkt Cap Rs m503,643608,481493,632389,034395,496 
No. of employees `00019.921.722.723.522.0 
Total wages/salary Rs m29,44631,17431,06832,14933,562 
Avg. sales/employee Rs Th7,565.77,184.66,259.06,070.87,032.8 
Avg. wages/employee Rs Th1,482.91,438.61,369.81,366.61,527.9 
Avg. net profit/employee Rs Th1,176.6983.2569.7402.5887.7 
DR. REDDYS LAB INCOME DATA
Net Sales Rs m150,233155,683141,961142,810154,482 
Other income Rs m2,7412,9501,7151,5523,375 
Total revenues Rs m152,974158,633143,676144,362157,857 
Gross profit Rs m34,93635,85324,72223,51231,782 
Depreciation Rs m7,5999,38910,26610,77211,348 
Interest Rs m1,082826634788889 
Profit before tax Rs m28,99628,58815,53713,50422,920 
Minority Interest Rs m00000 
Prior Period Items Rs m0229349344438 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m5,6327,5112,9654,3803,858 
Profit after tax Rs m23,36421,30612,9219,46819,500 
Gross profit margin %23.323.017.416.520.6 
Effective tax rate %19.426.319.132.416.8 
Net profit margin %15.613.79.16.612.6 
DR. REDDYS LAB BALANCE SHEET DATA
Current assets Rs m118,096117,94096,837104,984111,101 
Current liabilities Rs m63,73463,47184,19968,93858,973 
Net working cap to sales %36.235.08.925.233.7 
Current ratio x1.91.91.21.51.9 
Inventory Days Days6260737479 
Debtors Days Days99979810494 
Net fixed assets Rs m59,06573,352102,552104,385101,245 
Share capital Rs m852853829830830 
"Free" reserves Rs m107,482124,845121,792124,886139,406 
Net worth Rs m108,334125,698122,621125,716140,236 
Long term debt Rs m14,30710,6855,44925,08922,000 
Total assets Rs m190,650203,841218,165225,443224,656 
Interest coverage x27.835.625.518.126.8 
Debt to equity ratio x0.10.100.20.2 
Sales to assets ratio x0.80.80.70.60.7 
Return on assets %12.810.96.24.59.1 
Return on equity %21.617.010.57.513.9 
Return on capital %24.521.712.99.714.9 
Exports to sales %49.446.654.600 
Imports to sales %9.09.09.400 
Exports (fob) Rs m74,14672,61877,52000 
Imports (cif) Rs m13,48514,05013,27400 
Fx inflow Rs m74,87075,40581,67072,62388,673 
Fx outflow Rs m26,00827,11526,35518,91619,104 
Net fx Rs m48,86248,29055,31553,70769,569 
DR. REDDYS LAB CASH FLOW
From Operations Rs m 25,235 32,626 21,444 18,030 28,704 
From Investments Rs m -22,647 -20,394 -18,404 -14,883 -7,727 
From Financial Activity Rs m -4,332 -17,001 -3,692 -4,440 -21,326 
Net Cashflow Rs m -1,744 -474 -1,144 -1,236 -314 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 25.5%
Foreign collaborators 0.0%
Indian inst/Mut Fund 5.4%
FIIs 35.3%
ADR/GDR 18.5%
Free float 15.3%
Shareholders 75,885
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034
E-MAIL spoddar@drreddys.com WEB www.drreddys.com
TELEPHONE (040) 4900 2222 FAX (040) 4900 2999
SECTOR PHARMACEUTICALS GROUP Dr. Reddy's Group
TR AGENT Bigshare Services Ltd., G-10, Left wing, Amrutha Ville, Hyderabad - 82
AUDITOR B. S. R & Co.
CHM: G. V. Prasad COMP SEC: Sandeep Poddar YEAR OF INC: 1984 BSE CODE: 500124 FV (Rs): 5 DIV YIELD (%): 0.8

More Pharmaceuticals Company Fact Sheets:   DISHMAN PHARMA  AUROBINDO PHARMA  VENUS REMEDIES  FULFORD INDIA  ASTRAZENECA PHARMA  

Compare DR. REDDYS LAB With:   DISHMAN PHARMA  AUROBINDO PHARMA  VENUS REMEDIES  FULFORD INDIA  ASTRAZENECA PHARMA  

Compare DR. REDDYS LAB With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 318 Points Lower; Auto and Metal Stocks Witness Selling(Closing)

India share markets continued to witness selling pressure during closing hours and ended their day on a negative note.

Views on news

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (1QFY19); Net Profit Up 614.9% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 614.9% YoY). Sales on the other hand came in at Rs 37 bn (up 12.1% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound (Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On... (The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors (The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Union Budget 2019-2020: More Style Over Substance (The 5 Minute Wrapup)

Jul 5, 2019

Did the Union Budget announce measures to stimulate the economy and bolster corporate earnings growth?

Here's What to Do with Falling Small Cap Stocks (Profit Hunter)

Jul 10, 2019

There are some great buying opportunities in the market right now - and the small cap space is your best bet.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. REDDYS LAB

DR. REDDYS LAB - ASTRAZENECA PHARMA COMPARISON

COMPARE DR. REDDYS LAB WITH

MARKET STATS